cbdMD Inc
AMEX:YCBD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
cbdMD Inc
AMEX:YCBD
|
US |
Balance Sheet
Balance Sheet Decomposition
cbdMD Inc
cbdMD Inc
Balance Sheet
cbdMD Inc
| Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
4
|
5
|
15
|
26
|
7
|
2
|
2
|
2
|
|
| Cash Equivalents |
1
|
0
|
0
|
4
|
5
|
15
|
26
|
7
|
2
|
2
|
2
|
|
| Short-Term Investments |
0
|
0
|
1
|
2
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
4
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
1
|
1
|
0
|
4
|
5
|
5
|
4
|
4
|
2
|
3
|
|
| Other Current Assets |
1
|
0
|
1
|
1
|
4
|
3
|
3
|
3
|
1
|
1
|
1
|
|
| Total Current Assets |
1
|
1
|
4
|
12
|
16
|
24
|
37
|
16
|
8
|
6
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
2
|
10
|
8
|
5
|
4
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
2
|
10
|
8
|
5
|
4
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
2
|
2
|
|
| Intangible Assets |
1
|
1
|
3
|
3
|
22
|
22
|
23
|
18
|
3
|
3
|
2
|
|
| Goodwill |
0
|
0
|
0
|
0
|
55
|
55
|
57
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
55
|
55
|
57
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-11%
|
7
+344%
|
15
+111%
|
95
+530%
|
111
+17%
|
125
+13%
|
41
-67%
|
16
-60%
|
11
-35%
|
10
-2%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
|
| Accrued Liabilities |
0
|
1
|
1
|
0
|
1
|
4
|
4
|
3
|
3
|
5
|
2
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
1
|
2
|
2
|
1
|
4
|
8
|
7
|
5
|
5
|
9
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
51
|
23
|
15
|
4
|
2
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+225%
|
3
+123%
|
2
-17%
|
57
+2 271%
|
32
-44%
|
22
-32%
|
9
-57%
|
7
-24%
|
9
+20%
|
3
-63%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
5
|
6
|
7
|
60
|
47
|
73
|
147
|
174
|
182
|
179
|
|
| Additional Paid In Capital |
3
|
5
|
11
|
22
|
97
|
127
|
176
|
179
|
183
|
184
|
187
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
-71%
|
4
+950%
|
13
+200%
|
38
+198%
|
79
+111%
|
103
+30%
|
31
-70%
|
9
-71%
|
2
-78%
|
7
+268%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-11%
|
7
+344%
|
15
+111%
|
95
+530%
|
111
+17%
|
125
+13%
|
41
-67%
|
16
-60%
|
11
-35%
|
10
-2%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
5
|
5
|
5
|
5
|
2
|
|